Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0DY7W
|
|||
| Former ID |
DIB004175
|
|||
| Drug Name |
Nebracetam
|
|||
| Synonyms |
Memolog; WEB-1881; WEB-1881-FU
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-9: 332] | Phase 3 | [1] | |
| Company |
Boehringer Ingelheim Corp
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H16N2O
|
|||
| Canonical SMILES |
C1C(CN(C1=O)CC2=CC=CC=C2)CN
|
|||
| InChI |
1S/C12H16N2O/c13-7-11-6-12(15)14(9-11)8-10-4-2-1-3-5-10/h1-5,11H,6-9,13H2
|
|||
| InChIKey |
LCAFGJGYCUMTGS-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 97205-34-0
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Nefiracetam ameliorates associative learning impairment in the scopolamine-injected older rabbit. Med Sci Monit. 2002 Apr;8(4):BR105-12. | |||
| REF 2 | Effects of nebracetam (WEB 1881 FU), a novel nootropic, as a M1-muscarinic agonist. Jpn J Pharmacol. 1991 Jan;55(1):177-80. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.